Overview

Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia

Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of T-62 in subjects with postherpetic neuralgia.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Analgesics